HLS Therapeutics (HLS.V) Q2 2024 Earnings

9MayConfirmed
Q2 2024
-0.26
-0.25
-0.23
-0.22

Details

Expected EPS
-0.21703177200000004
Actual EPS
-0.2598364
Surprise EPS
-0.04
Surprise Percent
+19.72%

Description

HLS Therapeutics (HLS.V) has reported earnings of -0.2598364 per share for Q2 2024.

0 Comments

Share your thoughts